Why dismantling America’s biomedical innovation engine is a long-term threat to the very industry staying quiet about it. A recent piece by Steven Usdain, which was also highlighted by Holden Thorp, got me thinking: are...read more
Category - AI/Machine learning
When “Anonymous” Isn’t: The UK Biobank Data Exposure and the Limits of Health Data Privacy
The UK Biobank data exposure highlights a growing risk in modern health research: sensitive data is not only vulnerable to breaches, but to systemic leakage through normal scientific practices. This raises urgent...read more
From Surveys to Signals: How AI Is Changing Voice of the Customer in Life Sciences
From Surveys to Signals: How AI Is Changing Voice of the Customer in Life Sciences I’ve been spending some time thinking on how Voice of the Customer (VoC) programs are evolving as artificial intelligence (AI) becomes...read more
Tempus Scoops Up OneOme’s Pharmacogenetics Assets as Precision Medicine Shakeout Continues
Tempus AI has acquired the pharmacogenetics assets of OneOme, a once-promising precision medicine startup that abruptly shut down earlier this year amid financial troubles. The deal marks the latest in a flurry of...read more
